Nanomedicine using Quercus infectoria Extract for the treatment of Breast Cancer by Wan Nur, Suzilla et al.
Nanomedicine using Quercus infectoria Extract for the treatment of 
Breast Cancer 
 
Wan Nur Suzilla 1, Syed Mahmood 1,2, and Rajaletchumy Veloo Kutty 1,2* 
 
1 Faculty of Engineering Technology, Universiti Malaysia Pahang, 26300 Kuantan, Pahang. 
2 Center of Excellence for Advanced Research in Fluid Flow, University Malaysia Pahang, 
26300, Kuantan, Pahang, Malaysia 
*Corresponding author: vrajaletchumy@ump.edu.my  
 
Abstract: 
Drug resistance and metastasis appears to be a continuous challenging issue in spite of the 
evolvement that have been made in surgery, radiotherapy and targeted therapy. The 
recognition of natural product and their effect against the cancer treatment is continuously 
under exploration. Quercus infectoria (QI) galls is a special natural products formed through the 
interactions between plant hormones and insects. It has been used as a source of drugs for the 
treatment of cancerous diseases in traditional and folk medicines for centuries. However, the 
information on the phytochemical content and the cytotoxicity against breast cancer cells are 
not well established. Therefore in this study, QI galls is chosen for its evaluation for 
phytochemical constituents and cytotoxic activity against breast cancer cells (MDA-MB-231 and 
MCF-7). The QI galls extract was extracted by maceration extraction using 70% aqueous-
ethanol. The yield of extract obtained is 47.54%. Then, the crude extract was screened for their 
total phenolic content (TPC), total flavanoid content (TFC) and antioxidant assay. From the 
result, it was showed that the TPC is 672.22 µg/mg GA equivalent while the TFC is 4.8 µg/mg 
Rutin equivalent. The antioxidant assay was determined and the IC50 obtained for the QI galls 
extract is 44.5µg/ml. QI galls extract also quantified for gallic and tanic acid via liquid 
chromatography and content in extract was found to be 76.22 mg/g and 1794.18 mg/g 
respectively. Finally, the QI galls extract was screened for cytotoxic activity against breast 
cancer cells. From the result it was showed a promising result as the IC50 obtained for MCF-7 
was 0.961 µg/ml and for MDA-MB-231 was 9.61 µg/ml. For MCF7 cell line, it was showed that 
the IC50 value obtained was significantly higher (p < 0.05), than the docetaxel (5.67 µg/ml). The 
cytotoxic activity of the gallic acid (GA), tannic acid (TA) and combination of gallic and tannic 
acid (TA/GA) against MCF-7 and MDA-MB-231 cells also been determined. It was showed that, 
for MCF-7, the IC50 of GA was 4.03 µg/ml, TA was 9.61 µg/ml and combination of TA/GA was 
2.81 µg/ml. For MDA-MB-231 the IC50 of GA was 43.33µg/ml, TA was 74.25 µg/ml and 
combination of TA/GA was 37.5µg/ml. From this study, it was also showed that the QI galls 
extract inhibit the MCF-7 and MDA-MB-231 cell lines through the induction of apoptosis. The 
percentage of early apoptosis for the MCF-7 and MDA-MB-231 cell line after 72 hours 
treatment were 49.7% and 48.6% respectively. Interestingly, it was revealed that QI galls 
extract can be a potential source of natural antioxidants as well as a potent anticancer agent 
against breast cancer cells. 
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